Regulatory News
Wednesday, November 16, 2016
BRIEF-GTx achieves second stage 1 milestone in Phase 2 clinical trial
* Top line data from stage 1 of 9 mg cohort expected in
December 2016
Read more
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment